We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$16.3B
AUM Growth
+$1.54B
(+10%)
Cap. Flow
+$794M
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
20.21%
Holding
1,104
New
170
Increased
359
Reduced
380
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$274M |
| 2 |
General Motors
GM
|
+$175M |
| 3 |
Cigna
CI
|
+$139M |
| 4 |
Ford
F
|
+$133M |
| 5 |
Adobe
ADBE
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$193M |
| 2 |
Tesla
TSLA
|
+$181M |
| 3 |
Palo Alto Networks
PANW
|
+$164M |
| 4 |
Microsoft
MSFT
|
+$98.7M |
| 5 |
Cardinal Health
CAH
|
+$83.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.57% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Financials | 12.35% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
176
DELISTED
Veradigm Inc. Common Stock
MDRX
| $21.1M | 0.13% |
1,619,278
+69,280
| +4% | +$1.12M |
|
177
Schneider National
SNDR
$6.4B
| $21.1M | 0.13% |
788,295
-108,164
| -12% | -$2.92M |
|
178
Sylvamo
SLVM
$1.55B
| $21M | 0.13% |
454,998
+99,566
| +28% | +$4.73M |
|
|
EVBG
179
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $21M | 0.13% |
605,846
-44,827
| -7% | -$1.43M |
|
|
KYNB
180
Kyntra Bio
KYNB
$28.9M
| $20.9M | 0.13% |
44,765
-12,300
| -22% | -$6.51M |
|
181
AXIS Capital
AXS
$8.77B
| $20.8M | 0.13% |
381,458
-32,375
| -8% | -$1.88M |
|
182
Cerence
CRNC
$368M
| $20.7M | 0.13% |
736,152
+9,516
| +1% | +$244K |
|
183
CVR Energy
CVI
$3.43B
| $20.6M | 0.13% |
629,777
-10,699
| -2% | -$343K |
|
184
Caterpillar
CAT
$388B
| $20.6M | 0.13% |
+90,057
| New | +$21.8M |
|
185
Sprouts Farmers Market
SFM
$7.26B
| $20.5M | 0.13% |
584,996
+20,286
| +4% | +$656K |
|
186
World Kinect Corp
WKC
$2.08B
| $20.3M | 0.12% |
794,748
-44,854
| -5% | -$1.22M |
|
187
Guardant Health
GH
$19.1B
| $20.3M | 0.12% |
+864,454
| New | +$24.7M |
|
|
CPRX
188
DELISTED
Catalyst Pharmaceutical
CPRX
| $20.2M | 0.12% |
1,218,994
+1,100,381
| +928% | +$18.2M |
|
189
Dana Inc
DAN
$2.96B
| $19.9M | 0.12% |
1,321,447
+1,179,196
| +829% | +$19.3M |
|
190
Centene
CNC
$31.7B
| $19.6M | 0.12% |
310,864
+298,442
| +2,403% | +$21.2M |
|
191
Qualys
QLYS
$4.77B
| $19.5M | 0.12% |
149,910
+3,635
| +2% | +$426K |
|
|
AVTA
192
DELISTED
Avantax, Inc. Common Stock
AVTA
| $19.5M | 0.12% |
739,974
+201,974
| +38% | +$5.48M |
|
|
CCRN
193
DELISTED
Cross Country Healthcare
CCRN
| $19.4M | 0.12% |
868,939
+697,447
| +407% | +$18.3M |
|
194
Resideo Technologies
REZI
$5.47B
| $19.3M | 0.12% |
1,058,360
+616,947
| +140% | +$11.2M |
|
195
RLJ Lodging Trust
RLJ
$1.88B
| $19.2M | 0.12% |
1,810,757
-168,479
| -9% | -$1.89M |
|
196
Ionis Pharmaceuticals
IONS
$9.09B
| $19.2M | 0.12% |
536,688
-153,033
| -22% | -$5.75M |
|
197
NVR
NVR
$17.3B
| $19.2M | 0.12% |
3,437
+1,374
| +67% | +$7.09M |
|
198
LivaNova
LIVN
$4.51B
| $19.1M | 0.12% |
438,495
+167,567
| +62% | +$8.48M |
|
|
SYNH
199
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $18.9M | 0.12% |
531,673
+411,393
| +342% | +$14.9M |
|
200
Otis Worldwide
OTIS
$28.2B
| $18.8M | 0.12% |
222,224
+36,043
| +19% | +$2.98M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2023 Portfolio in Review
As of Q1 2023, Jacobs Levy Equity Management held 1,104 positions worth $16.3B, up 10% from $14.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management deployed $794M of net new capital in Q1 2023, opening 170 new positions and adding to 359 existing holdings. Its largest new stake was Cigna: 475,901 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Humana, an estimated $193M trimmed.
- Jacobs Levy Equity Management's largest Q1 2023 buy was Cigna: 475,901 shares worth $122M.
- Jacobs Levy Equity Management added most to Apple in Q1 2023, an estimated $274M increase.
- Jacobs Levy Equity Management's biggest Q1 2023 reduction was Humana, cutting an estimated $193M.
- Jacobs Levy Equity Management fully exited PayPal in Q1 2023, selling an estimated $66.4M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $16.3B portfolio in Q1 2023.
- Jacobs Levy Equity Management opened 170 new positions and closed 160 in Q1 2023.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $16.3B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2023, filed 15 May 2023.